Literature DB >> 11312003

Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.

M Higaki1, Y Azechi, T Takase, R Igarashi, S Nagahara, A Sano, K Fujioka, N Nakagawa, C Aizawa, Y Mizushima.   

Abstract

The use of biodegradable polymer matrices as a single-dose vaccine delivery system was investigated using tetanus toxoid (TT) and diphtheria toxoid (DT). BALB/c mice were immunized with TT or DT in different formulations including individual, in minipellet and aluminum hydroxide (alum), and the antibody responses were monitored for 48 weeks. Antigens entrapped in minipellet elicited higher antibody responses compared to those obtained with individual antigens and antigens adsorbed to alum and the antibody levels remained elevated over 48 weeks. In addition, minipellet formulations induced the same subclasses of antibodies induced by alum formulations. These results raise the possibility to obtain optimal and long-lasting immune responses by a single administration of minipellet formulations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312003     DOI: 10.1016/s0264-410x(01)00039-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  cDC1 IL-27p28 Production Predicts Vaccine-Elicited CD8+ T Cell Memory and Protective Immunity.

Authors:  Augustus M Kilgore; Nathan D Pennock; Ross M Kedl
Journal:  J Immunol       Date:  2019-12-23       Impact factor: 5.422

Review 2.  Germinal center enhancement by extended antigen availability.

Authors:  Kimberly M Cirelli; Shane Crotty
Journal:  Curr Opin Immunol       Date:  2017-07-21       Impact factor: 7.486

Review 3.  Sustainable Applications of Animal Waste Proteins.

Authors:  Svetlana Timorshina; Elizaveta Popova; Alexander Osmolovskiy
Journal:  Polymers (Basel)       Date:  2022-04-14       Impact factor: 4.967

Review 4.  Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.

Authors:  Nattawut Leelakanok; Sean Geary; Aliasger Salem
Journal:  J Pharm Sci       Date:  2017-10-16       Impact factor: 3.784

5.  Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves.

Authors:  Fawad Mansoor; Bernadette Earley; Joseph P Cassidy; Bryan Markey; Simon Doherty; Michael D Welsh
Journal:  BMC Vet Res       Date:  2015-08-21       Impact factor: 2.741

Review 6.  Controlling timing and location in vaccines.

Authors:  Darrell J Irvine; Aereas Aung; Murillo Silva
Journal:  Adv Drug Deliv Rev       Date:  2020-06-26       Impact factor: 15.470

7.  Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses.

Authors:  Gabriel Kristian Pedersen; Katharina Wørzner; Peter Andersen; Dennis Christensen
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

Review 8.  Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.

Authors:  Giuseppe Lofano; Corey P Mallett; Sylvie Bertholet; Derek T O'Hagan
Journal:  NPJ Vaccines       Date:  2020-09-18       Impact factor: 7.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.